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Abstract. 
Introduction: The problem of complex therapy of acne attracts the attention of researchers 
because it accompanied with significant cosmetic defect and caused serious patient’s 
experiences.  
Objectives: The aim of this study was to find ways to increase the efficacy and safety of 
treating patients with acne by complex pharmacological correction of its manifestations. 
Methods: The study included 110 people (32 men and 78 women) aged from 17 to 35 
years, divided into 5 equal groups (according to the type of therapy) and observed for 6 
months. All the patients underwent a comprehensive examination, including calculation of 
the dermatological index of acne (DIA), psychometric tests  as well as an immunological 
study. 
Results and discussion: Monotherapy with combined topical agents leads to a decrease in 
DIA (48.75%) and the length of remission for more than 6 months in 46.4% of 
observations. Phabomotisol decreased DIA count and improved psychometric parameters. 
Ionized liquid (IL) led to an increase in CD4 + lymphocytes (14.48%) and 
immunoregulatory index (40.88%), decreased in the number of CD8 + lymphocytes 
(17.92%). The most effective combination was phabomotisol and IL (negative redox 
potential): DIA decreased (74.36%), remission of more than 1 year was observed in 22.7% 
patients.  
Conclusion: Effectiveness therapy with phabomotizol was shown. Effectiveness of IL in 
the complex treatment of acne in the medium-severe course of the disease is estimated for 
the first time. Presence of immunotropic properties of IL was established. Possibility of 
achieving long-term remission without the use of antibiotic therapy was demonstrated. 
Keywords: acne, adolescence, adult, acne complex therapy, psycho-emotional state, 
pharmacological correction, phabomotizol, ionized liquor, redox potential. 
 
Introduction 
Acne is the most common skin disease. It 
occurs in about 85-95% of people aged 12-30 
years and in 50% of patients – over 25 years [1, 2, 
3]. The peak incidence corresponds to the period 
of social formation and psychological approval of 
a person [4, 5]. Acne is not a disabling pathology, 
but it can cause serious emotional disturbances. 
Patients with acne have a significant range of 
psychological changes: anxiety disorders, 
dysmorphophobia, pathomimia, eating disorders, 
depression [6, 7, 8]. Severity of depressive 
symptoms is proportional to the degree of 
cosmetic defect in most cases [9, 10]. 
The pathogenetic basis of acne is 
hyperproduction of sebum, retentional 
hyperkeratosis of the sebaceous-hair follicle, 
proliferation of propionbacteria acne and 
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inflammation [1, 8, 9]. The presence of receptors 
in the sebaceous glands for neurotransmitters that 
are released in response to stimulation has also 
been established. It corresponds to the role of 
stress in enhancing of acne [9, 10, 11]. 
A variety of agents for the treatment of acne 
have been proposed. The main ones are systemic 
and topical antibacterial preparations of the group 
of tetracyclines, lincosamides, systemic and 
topical retinoids, which combined with oral 
contraceptives [1, 12, 13, 14, 15, 16, 17]. 
Systemic isotretinoin possesses indisputable 
efficacy in the cases of severe form of acne [18, 
19]. However, many side effects and the absolute 
teratogenicity of this drug limits its wide 
application. Systemic antibacterial drugs 
(tetracycline, doxycycline, minocycline) act only 
on the ancestor propionbacteria without 
embracing other pathogenetic mechanisms [1, 2, 
11, 16, 17, 20]. Yet they remain the drugs of 
choice for the treatment in case of moderately 
severe acne. The drugs are administered for a 
period of 7 days to several months, but in that case 
they have a significant negative impact on the 
microbiocenosis of the intestine and mucous 
membranes. Previous studies indicate the 
presence of changes in immunological parameters 
such as the increase in the content of CD8+ 
lymphocyte fraction, the decrease in the level of 
CD3+ and CD4+ populations of T-lymphocytes, 
the decrease in the immunoregulatory index 
(IRI=CD4+/CD8+) and the positive effect of 
immunomodulators in the complex treatment of 
acne [1, 16, 17, 18, 20]. Antibiotics and agents 
that affect immunity have several side effects. 
When they are combined, the pharmacological 
load and the spectrum of contraindications as well 
as the frequency of unwanted reactions increase. 
The greatest number of acne sufferers are 
teenagers with mild to moderate form [4, 9]. In 
this age group, it is better to prescribe drugs for 
topical use due to significant limitations and side 
effects of systemic drugs. However, the main 
topical anti-acne preparations (alcohol solutions 
of clindamycin, erythromycin, benzoyl peroxide, 
retinoids – adapalene compound) have side 
effects in the form of erythema, dryness and 
flaking of the skin. These reasons can cause 
premature self-canceling of the treatment by a 
patient. 
Understanding the role of immunological, 
psychosomatic changes in acne as well as positive 
assessment of the prospects for the use of 
appropriate drugs creates the prerequisites for the 
search of new effective and safe schemes of 
complex correction of this disease [21, 22]. The 
effectiveness of the use of psychotropic drugs in 
a number of patients with acne was proven [23, 
24]. Many scientific researches suggested these 
methods of pharmacological correction for use in 
practical medicine about 10 years ago [1, 11, 12, 
25]. However, there is no data on the use of 
phabomotisol in this disease. Ionized liquids with 
positive and negative oxidation-reduction 
potential that are used for the first time in the 
treatment of acne are currently prescribed to treat 
eczema and psoriasis in dermatology and to treat 
purulent wounds in surgery [26]. 
The purpose of this study is to find the way 
for the improvement of the effectiveness and 
safety of treatment in patients with moderate acne 
by using complex pharmacological correction of 
psychoemotional, immunological changes and 
cutaneous manifestations of acne. 
Objectives 
1. Investigate the possibilities of standard 
acne therapy. 
2. Study the effectiveness of treatment of 
moderate acne with the use of topical  
monotherapy. 
3. Establish the possibility of including in the 
complex therapy of acne anxiolytics such as 
phabomotisol and synthesized ionized liquids 
with different oxidation-reduction potential. 
4. Conduct a comparative analysis of various 
programs for the treatment of acne according to 
clinical, psychoemotional and immunological 
indicators. 
5. To substantiate the application of the most 
effective and complex ways for pharmacological 
correction of psychoemotional, immunological 
disorders and cutaneous manifestations of acne. 
Scientific novelty of the study 
The therapeutic efficacy of phabomotisol in 
the correction of psychoemotional changes in 
acne has been proved for the first time. It has been 
demonstrated that a combination of standard 
external therapy with taking phabomotisol in a 
dose of 5 mg 3 times a day during a month 
effectively corrects psychoemotional changes and 
cutaneous manifestations of acne. 
A positive effect of innovative external 
therapy (anti-inflammatory lotion containing 3% 
alcohol solution of chloramphenicol once a day in 
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the morning 2 to 4 weeks, a peeling lotion 
containing benzoic acid 1.0, salicylic acid 2.0, 
camphor alcohol 5-15.0, boric acid 3.0, 
Streptocide 7.0 and whitening ointment 
containing zinc, boric acid at 1.5-2.5, 30% 
hydrogen peroxide 0.5 and zinc ointment 25.0 at 
night once a day on the skin of the face, excluding 
the paraorbital area, for 2-4 months) has been 
established. 
The evidence of the immunomodulatory 
action of a liquid with negative AFP that is 
administered at a dose of 2 ml/kg of body weight 
was received by the basis of changes in the 
immunograms of patients with acne. 
New data has been obtained on the positive 
effect of ionized fluids with positive and negative 
redox potential on acne eruptions and post-acne 
changes. 
A positive pharmacodynamic interaction of 
phabomotisol and ionized liquid with a negative 
redox-potential was established, which is 
expressed in the greater effectiveness of their 
combination compared to the separate application 
with the standard external agents. This 
combination can be considered optimal for 
reducing the dermatological index of acne (DIA) 
and increasing the duration of remission. This 
therapeutic method allows to abandon the use of 
systemic antibiotic therapy. The incidence of side 
effects decreases from 81.2% to 4.5% in the case 
of using complex therapy as a combination of 
topical agents, phabomotisol and ionized fluids 
with different AFP. 
The theoretical significance of the work lies 
in the development of a system that makes it 
possible to assess the possibility of changing the 
therapeutic activity of a pharmacological agent by 
changing the redox potential of body fluids. For 
practical medicine, the prospect of a 
comprehensive correction of acne with the use of 
phabomotisol and liquids with various oxidation-
reduction potentials against the background of 
standard external pharmacotherapy has been 
proved. This allows to optimize treatment, 
withdraw from the systemic antibacterial drugs, 
minimize the frequency of side effects, increase 
the duration of remission, reduce the cost of 
treatment, which makes it reasonable to use the 
proposed scheme of dermatology and 
cosmetology. New data obtained in this study can 
supplement the relevant courses in dermatology, 
cosmetology, pharmacology, clinical 
pharmacology. 
All the studies were carried out in accordance 
with the requirements of the current guidelines: 
the ethical norms of the Helsinki Declaration of 
1964, modified by the 41st World Assembly 
(Hong Kong, 1989) and the 52nd General 
Assembly of the WMA (Edinburgh, Scotland, 
UK, 2000), the Lisbon Declaration on the Rights 
of Patients, (Lisbon, Portugal, 1981), in section V 
of the Code of Medical Ethics, approved by the 
XVIII All-Russian Pirogov Congress of 
Physicians (07.06.1997). All patients signed 
informed consent, allowing at any time to stop the 
study. 
Personal contribution to the study 
Personal contribution consists in the direct 
participation of the author of the thesis in the 
study of many scientific sources of Russian and 
foreign literature, the selection of patients for 
participation in the study, filling out individual 
medical records, in systematizing and statistical 
processing of the data obtained and analyzing the 
results. 
Methods 
All patients with papulo-pustular form of 
acne were on outpatient treatment at the DKB at 
st. Voronezh-1 RZhD in the period from 2010 to 
2014 inclusively. The work was carried out at the 
Stationary Unit No. 3 of DKB (the Chief Doctor 
– Doctor of Medical Sciences, Professor 
Novomlinsky V.V.), the Department of 
Pharmacology and the Department of 
Dermatovenereology of the VSMU named after 
N.N. Burdenko (Rector – Professor 
I.E. Esaulenko). The results of the examination 
and treatment of 110 patients of different sexes – 
32 men (29.09%) and 78 women (70.9%) with 
acne of moderate severity were used for the thesis. 
Diagnosis – Acne vulgaris (L70.0) – was 
delivered in accordance with the X International 
Classification of Diseases on the basis of clinical 
and anamnestic data. 
The majority of the subjects had an age of 16 
to 25 years, which corresponds to literary data on 
the incidence of acne. Based on the clinical 
picture and by counting the elements of the rash, 
we evaluated the condition of the patients and 
included acne with a moderate degree of severity 
in the study. For the quantitative evaluation of 
each type of acne-elements, the dermatological 
index of acne (DIA) was calculated in points. The 
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duration of the disease varied from several 
months to 10 years. During this time, patients 
either did not seek help expecting spontaneous 
cure or visited cosmetic rooms. Some of them 
previously underwent outpatient treatment (with 
greater or less effectiveness), which did not allow 
achieving a stable remission. 73.6% (81 patients) 
of young men and women showed a background 
somatic pathology – diseases of ENT and 
gastrointestinal tract, allergic reactions. 
The criteria for inclusion in the study were: the 
presence of the disease – acne of moderate 
severity and post-acne changes (atrophic scars, 
post-inflammatory pigmentation, breach of skin 
microrelief), age from 17 to 35 years, written 
informed consent of the patient. The criteria for 
exclusion were: indication of the diseases in the 
acute stage, diabetes mellitus, pregnancy, 
lactation, individual intolerance of the proposed 
therapy, disagreement of the patient. 
All patients were assigned standard 
laboratory tests – a general blood test, a 
biochemical blood test, a hormonal status. 
Subjects with the revealed endocrine pathology 
and changes in the content of sex hormones from 
laboratory data were sent to the appropriate 
specialists. In addition, the parameters of cellular 
and humoral immunity (number of T and B 
lymphocytes, immunoglobulins Ig M, Ig G, Ig A, 
immunoregulatory index (IRI=CD4 +/CD8+) 
were estimated additionally. The value of the 
dermatological index of acne-DIA was calculated 
by the formula A + B + C + D, where A is the 
score by the number of comedones, B is the 
number of pills, and C is the number of pustules 
and D – nodes. The patient's psychometric data 
was assessed by determining the levels of anxiety 
and depression on the Tsung scale, State of health, 
activity, mood. 
Regardless of age and sex, patients were 
randomly assigned to 5 groups (22 patients each) 
using a randomization table in accordance with 
the treatment regimen used. In the first group (n = 
22) patients were prescribed standard therapy – 
doxycycline monohydrate tablets ("Unidox 
Solutab") 100 mg twice a day for 7-14 days, 
topicals – combination of adapalene with 
clindamycin (gel "Clenzite-C") 1 time per day for 
2-4 weeks, then – adapalene (gel "Clenzite") 2-4 
months. A cream with 20% azelaic acid 
(Skinoren) was applied 2 times a day 2-4 months 
after the main course of treatment to prevent 
exacerbations and post-acne correction. To 
normalize the intestinal microflora, all patients 
within 14 days in addition received capsules 
containing Lactobacillus acidophilus, 
Bifidobacterium infantis, Enterococcus faecium 
("Linex" preparation) 1 capsule 3 times a day. 
Sunscreen was prescribed if treatment took place 
in summer. 
The second group (n = 22) consisted of 
patients who did not receive systemic drugs. For 
topical therapy, combined topical agents were 
used in the form of an anti-inflammatory lotion 
containing 3% alcohol solution of 
chloramphenicol once a day in the morning 2-4 
weeks, a peeling lotion containing benzoic acid 
1.0, salicylic acid 2.0, camphor alcohol 5-15.0, 
boric acid 3.0, Streptocide 7.0, and bleaching 
ointment containing zinc, boric acid at 1.5-2.5, 
30% hydrogen peroxide 0.5 and zinc ointment 
25.0, at night once a day on the skin of the face, 
excluding the paraorbital area, for 2-4 months. In 
addition, a moisturizing lipid-replenishing day 
cream was prepared from medicinal cosmetics for 
problem skin and sunscreen for treatment in the 
summer. 
In the third group of patients (n = 22), in 
addition to the above-described topical combined 
external agents of standard therapy, phabomotisol 
was administered at 5 mg 3 times a day for a 
month. 
The fourth group of patients (n = 22) did not 
receive any drugs internally. For external therapy, 
the same combination of topical anti-
inflammatory agents in the form of lotion, lotion-
peeling and whitening ointments were used. 
Ionized fluids with different AFP were appointed 
in accordance to the protocol of the study based 
on the patient's written consent and permission of 
the Ethics Committee. Anolit − ionized fluid with 
a positive redox potential (ORP =+600 +900, pH 
= 6 − 7) was used in the form of applications 
locally 1 − 2 times daily 2 − 4 weeks. Catholyte − 
ionized fluid with a negative redox potential 
(ORP = −400 − 500, Ph = 8 − 9) was administered 
internally in a dose of 2 mL/kg body weight 1 
times a day for 14 days. Ionized fluid was 
obtained in an electrolytic cell «Karat-M» Tu 
3468-001-51702726-2006, certificate of 
conformance № ROSS RU AJA60V21343, from 
bottled spring water. 
The fifth group used complex therapy 
including the topical multicomponent agents 
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described above and containing chloramphenicol, 
streptocid, benzoic, boric and salicylic acids, 
camphor alcohol, zinc, and anolyte externally. 
Fabomotizol in the dose of 5 mg 3 times a day for 
a month and catholyte in the dose of 2 ml per kg 
of body weight once a day for 14 days were 
administered internally. 
The results were evaluated before the 
treatment and after 1, 3 and 6 months of therapy 
on the basis of patient complaints, their subjective 
sensations, changes in the clinical picture, 
dynamics of DIA and psychometric tests, and also 
on the basis of changes in the parameters of 
cellular and humoral immunity. DIA was 
determined before and during treatment – after 1, 
3 and 6 months. Psychometric tests were 
performed before and 3 months after the therapy. 
The immunogram was evaluated at the beginning 
of the study and within 20 days after the end of 
the catholyte intake. The data were recorded and 
statistically processed. During the statistical 
analysis, methods of descriptive variational 
statistics were used. Correlation analysis was used 
to identify the relationship among the features 
being investigated. Regression analysis was used 
to establish the nature of the dependencies of 
variables. The results were processed in IBM 
SPSS Statistics v.22 and Microsoft Office Excel 
2003 SP3 in the Windows 7 operating system. 
Various pharmacotherapeutic methods for 
the therapy of acne of moderate severity were 
used in the work. 
Results and discussion 
The first group (therapy included 
doxycycline monohydrate and bifidopreparation 
internally, a combination of adapalene with 
clindamycin, azelaic acid externally) included 22 
patients (6 young people and 16 girls). The 
dermatological index of acne before treatment 
ranged from 6 to 10 and averaged 7.1 points. 
Duration of the disease was from 6 months to 5 
years. Six months after the start of standard 
therapy, DIA on average decreased by 33.12% 
and corresponded to mild acne in 45.5% of 
patients (Figure 1). 
 
 
Fig. 1. Dynamics of changes in DIA (scores) in 
each patient with standard therapy 
 
During the therapy, the following side effects 
were revealed: redness, dryness, burning, 
dyspeptic disorders, which were noted by 18 
people (81.8%). Standard treatment promoted the 
onset of remission on average by 2.5 months 
(Figure 2). 
 
 
Fig. 2. Duration of remission in patients with 
acne (standard therapy, %) 
 
When studying the parameters of the 
immunogram before and after the treatment, 
serious differences were not found in the patients 
of the first group, which leads to the conclusion 
that the standard complex therapy of acne does 
not significantly affect the parameters of the 
immune response. 
After 3 months from the beginning of the 
main course of the treatment, positive changes in 
the indicators of the psychoemotional status of the 
patients of the first group were recorded. Their 
dynamics is presented in Table 1. 
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Table 1 
Dynamics of psychometric indicators (М±m, score, %) standart treatment (n=22) 
 
№ Index 
Terms of observation 
Before treatment  After treatment 
1 Anxiety 30.91 ± 1.28 28.91± 1.07⃰ (93.53%) 
2 Depression 39.00 ± 1.52 35.50 ± 1.21⃰ (91.03%) 
3 Health 29.36 ± 0.97 35.95 ± 1.09⃰ (122.45%) 
4 Activity 27.61 ± 0.74 33.89 ± 1.12* (122.75%) 
5 Mood 30.52 ± 0.86 36.18 ± 0.99⃰ (118.55%) 
Note: * − р<0.05 compared with the indicators before treatment 
 
 
 
Thus, after 6 months from the beginning of 
the treatment, the DIA index on average 
decreased by 33.12%, anxiety of patients 
decreased by 6.47%, depression – by 8.97% and 
SAN test data improved by an average of  
21.25%. Remission for more than half a year was 
observed in 18.2% of cases and averaged 2.5 
months. Adverse effects of therapy were noted by 
81.4% of patients (p<0.05). 
In 22 patients (5 young people and 17 girls 
aged 17 to 24 years) of the second group, the 
duration of the disease was from 1 to 6 years and 
DIA averaged 7.3 points. For acne therapy, only 
the above-described combined topical agents 
were used. One month after the start of the 
treatment, in 63.6% of patients, DIA decreased to 
mild acne and six months later decreased by 
48.75% (p<0.05). A graphic representation of the 
dynamics of the DIA is shown in Figure 3. 
 
Fig. 3. Dynamics of changes in DIA (scores) in 
each patient in the appointment of combined 
topical therapy 
 
The duration of clinical remission exceeded 
that for the administration of systemic antibiotic 
therapy and averaged 5.3 months (Figure 4). 
Fig. 4. The duration of remission in patients with 
acne in the appointment of combined topical 
therapy, % 
 
Side effects of the therapy (flaking, erythema 
and dry skin sometimes) were noted by patients in 
2 cases (9.1%). 
When studying the parameters of the 
immunogram before and after the treatment, no 
significant differences were found in the patients 
of the second group. Thus, acne therapy with 
standard combined topical drugs did not affect the 
immune status indicators of the subjects. 
After improvement of the clinical picture of 
the disease, according to the data of the anxiety, 
depression and SAN scales, positive changes 
were observed: in the majority of patients, anxiety 
and depression indicators decreased and SAN 
increased (Table 2). 
Thus, as a result of therapy with combined 
topical agents, anxiety of patients decreased by 
11.06%, depression by 12.71%, SAN test data 
improved by an average of 28.3%. The DIA 
indicator on average decreased by 48.75%. 
Remission of more than 6 months was observed in 
46% of cases. The side effects of the therapy were 
sometimes noted by 9.1% of patients (p<0.05).  
 
 Samodai O.V., Reznikov K.M. Complex correction of psychoemotional and immunological changes 
in patients with acne. Research result: pharmacology and clinical pharmacology. 2017;3(3):97-109. 103 
 
September. 2017. 3(3). Res Result Pharmacol Clin Pharmacol. rrpharmacology.ru  
Table 2 
Dynamics of psychometric indicators (М±m, score, %) of patients with the appointment  
of combined topical therapy (n=22) 
 
№ Index 
Terms of observation 
Before treatment After treatment 
1 Anxiety 31.64 ± 1.26 28.14 ± 0.98⃰ (88.94%) 
2 Depression 37.55 ± 1.40 32.77 ± 1.83⃰ (87.29%) 
3 Health 28.68 ± 0.95 37.14 ± 0.92⃰ (129.48%) 
4 Activity 27.44 ± 0.92 35.48 ± 0.98* (129.3%) 
5 Mood 29.23 ± 1.04 36.87 ± 1.02⃰ (126.14%) 
Note: * − р<0.05 compared with the indicators before treatment.
Changes in the clinical picture and 
psychoemotional status of patients with acne when 
phabomositol was included in the program of the 
treatment. In the third group (n = 22), including 7 
young people and 15 girls aged from 18 to 27 years, 
in addition to combined external therapy, 
phabomotisol was administered internally in a dose 
of 5 mg 3 times a day for a month. The duration of 
the disease varied from 6 months to 5 years. The 
average index of DIA was 7.1 points. After 6 
months of therapy, the DIA index decreased by 
56.41% (p<0.05) and was equal to 1 in 36.4% of 
patients. The skin was almost pure. All patients 
noted the disappearance of fatty gloss on the face, 
which is associated with the normalization of sebum 
and the effect of lightening the skin. A graphic 
representation of the intensity of the rash in patients 
receiving external therapy in combination with 
phabomotisol is shown in Figure 5. 
 
Fig. 5. Dynamics of changes in DIA (scores) in 
each patient treated with phabomotisol 
 
A sufficient effectiveness of treatment is 
confirmed by a decrease in the frequency of side 
effects. Most of the subjects did not make any 
complaints. Redness and dryness of the skin were 
sometimes noted only by 2 patients treated in the 
autumn-winter period. The duration of remission 
also increased (p <0.05) and averaged 5.2 months 
(Figure 6). 
 
 
Fig. 6. Duration of remission in acne patients 
treated with phabomotisol, % 
 
According to the received data, the main 
indices of the immunograms of the subjects were 
not changed significantly. Mathematical 
processing of the obtained results showed no 
significant effect of the inclusion in the therapy of 
phabomotisol on the immune status of patients of 
the third group. 
The results of therapy indicate a decrease in 
anxiety rates by 20.55%, depression by 12.81% 
and an increase in SAN scores by an average of 
32.03% (p<0.05). These changes in the 
psychometric parameters of patients in the third 
group are presented in Table 3. 
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Table 3 
Dynamics of psychometric indicators (М±m, score, %) of acne patients treated with fabomotisol (n=22) 
 
№ Index  
Terms of observation 
Before reatment After treatment 
1 Anxiety 31.64 ± 1.39 25.14±0.73⃰ (79.45%) 
2 Depression 34.77 ± 1.49 30.32 ± 0.91⃰  (87.19%) 
3 Health 27.59 ± 0.94 36.69 ± 0.92⃰ (132.98%) 
4 Activity 28.91 ± 0.88 37.55 ± 0.82⃰ (129.87%) 
5 Mood 26.98 ± 0.91 35.95 ± 0.88 *(133.24%) 
Note: * − р<0.05 compared with the indicators before treatment.
 
Mathematical processing of the obtained data 
indicates more significant changes in the clinical 
picture of this group than in the previous groups: 
DIA decreased by 56.41% (p<0.05), remission of 
more than 1 year was observed in 18.2% of cases, 
the side effects of the therapy were sometimes 
noted by 9.1% of patients (p<0.05). A significant 
decrease in anxiety scores was detected – by 
20.55% (p<0.05). Analyzing the presented 
results, we came to the conclusion that this effect 
can be explained by the inclusion of phabomotisol 
in the treatment program. The effectiveness of 
therapy for acne disease when included in the 
treatment of ionized fluids. 
According to the design of the study, the 
number of patients in the fourth group 
corresponded to the previous (n = 22) – 6 young 
people and 16 girls aged 18 to 26 years. The 
duration of the disease varied from 1 to 7 years. 
The dermatological index of acne was consistent 
with the diagnosis and averaged 6.9 points. In 
addition to the combined topical drugs, according 
to the study protocol, patients were assigned 
ionized fluids: anolyte (ORP = + 600 + 900, pH = 
6-7) was used locally for inflammatory elements 
1-2 times a day for 2-4 weeks and catholyte (ORP 
= -400-500, pH = 8-9) was administered 
internally in a dose of 2 ml / kg body weight once 
a day for 14 days. 
After half a year of observation and treatment 
in 50% of cases, the skin was practically clean, the 
dermatological acne index was equal to 1-2 
points. On average, the number of rashes 
decreased by 61.84% (p <0.05). A graphic 
representation of the positive effect of treatment 
on the dynamics of DIA of each patient of the 
fourth group is shown in Figure 7. 
 
 
Fig. 7. Dynamics of changes in DIA (scores) in 
each patient patients when included in the 
treatment of ionized fluids 
 
Only 1 person (4.5% of cases) during the 
treatment experienced redness and dryness of the 
skin. The remission of patients of the fourth group 
averaged 5.5 months (Figure 8). 
 
 
Fig. 8. Duration of remission of patients 
with acne when included in the treatment of 
ionized liquids, % 
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Analysis of the patients' immunograms 
revealed significant positive changes after the 
treatment: CD8 + lymphocyte count decreased 
by 16.9%, CD4 + lymphocyte count increased 
by 13.52%, immunoregulatory index (IRI) 
increased by 38.73% (p <0.05 ). 
After the therapy, anxiety and depression 
levels on the Tsung scale were significantly 
reduced. The dynamics of the investigated 
parameters is presented in Table 4. 
Thus, as a result of the therapy, DIA
decreased by 61.84% (p <0.05), the average 
duration of remission was 5.5 months. Side 
effects of the therapy were observed in 4.5% of 
cases. Mathematical processing of data made it 
possible to reveal more positive dynamics of the 
results of psychometric tests after the treatment 
in this group than in previous groups: anxiety of 
patients decreased by 22.53% (p <0.05), 
depression – by 19.11%  
(p <0.05), the indices for the SAN test improved 
by an average of 49.03% (p <0.05). 
Table 4 
Dynamics of psychometric indicators (М±m, score, %) in patients with the  
inclusion of ionized fluids (n=22) 
 
№ Index  
Terms of observation 
Before reatment After treatment 
1 Anxiety 31.27 ± 1.27 24.23 ± 0.70⃰ (77.47%) 
2 Depression 36.86 ± 1.33 29.82 ± 0.77⃰ (80.89%) 
3 Health 28.05 ± 0.78 42.64 ± 1.17⃰ (152.03%) 
4 Activity 29.27 ± 0.81 43.41 ± 1.1* (148.3%) 
5 Mood 28.52 ± 0.9 41.86 ± 0.97⃰ (146.77%) 
Note: * − р<0.05 compared with the indicators before treatment.
 
The use of phabomotisol and ionized fluids 
with positive and negative AFP in complex acne 
therapy. 
According to the protocol of the study, the 
number of patients in the fifth group who 
received complex therapy was 22 people – 8 
young people and 14 girls aged 18 to 28 years. 
The duration of the disease varied from 1 to 10 
years. Before the start of therapy in this group, 
the dermatological index of acne averaged 7.1 
points. In addition to combined topical agents 
and anolyte externally, patients were prescribed 
phabomotizol in a dose of 5 mg 3 times a day 
for a month and catholyte in a dose of  2 ml / kg 
body weight once a day for 14 days internally. 
A month after the start of the treatment in 
68.2% of cases, DIA decreased to light acne by 
30.77% (p <0.05). After 3 months, 36.4%  
(p <0.05) of the rash virtually disappeared DIA 
1-2). On average, the number of rashes 
decreased by 56.41% (p <0.05). After a half of 
a year of the observation and treatment, 81.2% 
of patients did not complain, because the skin 
was practically clean of the acne-elements. 
Only comedones were present in the seborrheic 
zones. The level of decline in DIA as a whole 
was 74.36% (p <0.05). In all, one patient (4.5%) 
was noted to have tightness of the skin 
(sometimes). A graphic depiction of the 
decrease in the intensity of acne eruptions in 
patients of the fifth group is shown in Figure 9. 
 
 
Fig. 9. Dynamics of changes in DIA (scores)  
in each patient treated with phabomotisol  
and ionized fluids 
 
The results obtained also demonstrate an 
increase in the duration of remission, which 
averaged 6.1 months and 22.7% of patients 
continued for more than 1 year (Figure 10). 
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Fig. 10. The duration of remission when included 
in the treatment of acne fabomotisol and ionized 
fluids, % 
 
After inclusion in the treatment regimen of 
acne phabomotisol and ionized fluids, the 
patient's immunograms changed significantly 
(table 5): the number of CD4 + T-cells increased 
by 14.48%, the immunoregulatory index 
increased by 40.88%, the number of cytotoxic 
CD8 + lymphocytes decreased by 17.92%  
(p <0.05). 
Table 5 
Dynamics of changes in immunological indices (М±m, UD, %) of patients treated with phabomotisol 
and  ionized fluids (n=22) 
 
№ 
Indicators 
immunity 
Terms of observation 
Percent changes 
Before reatment After treatment 
1 Leukocytes 6.26 ± 0.35 6.07 ± 0.17 96.7 
2 Lymphocytes 25.41 ± 1.66 28.55 ± 1.46* 115.17 
3 CD3+ 71.93 ± 1.67 73.16 ± 1.16 101.91 
4 CD19+ 9.53 ± 0.91 10.90 ± 0.79 107.78 
5 CD4+ 36.31 ± 1.69 41.05 ± 1.71* 114.48 
6 CD8+ 27.32 ± 1.14 22.50 ± 0.85* 82.08 
7 
Immunoregulatory 
index 
1.36 ± 0.10 1.89 ± 0.11* 140.88 
8 NK 10.07 ± 1.06 10.01 ± 0.76 98.96 
9 
Phagocytic activity 
of neutrophils 
59.55 ± 1.47 63.68 ± 1.35* 88.22 
10 lgG 13.34 ± 0.67 11.79 ± 0.44* 86.84 
11 lgM 1.87 ± 0.13 1.63 ± 0.08* 88.29 
12 lgA 2.40 ± 0.18 2.10 ± 0.14 11.71 
Note: * − р<0.05 compared with the indicators before treatment. 
 
 
According to the obtained data on the change 
in the psychoemotional state of patients (Table 6), 
as a result of treatment of patients in the fifth 
group, anxiety rates decreased by 25.68% (p 
<0.05), depression by 15.17% (p <0.05), The 
results of the SAN test improved by 52.75% (p 
<0.05). 
Analyzing the presented results, it can be 
concluded that a pronounced clinical effect (a 
decrease in DIA by 74.36%) and the longest 
remission (an average of 6.1 months) were 
observed with the inclusion of phabomotisol and 
ionized fluids in the combination of topical acne 
therapy. 
Comparative analysis of acne treatment 
results using different therapy programs. 
One of the main indicators of the 
effectiveness of the treatment is the magnitude of 
DIA, which characterizes the degree of positive 
changes in skin condition. Analysis of the 
obtained data shows that in the fifth group the 
decrease in the intensity of the precipitation was 
maximal: after 6 months, decreasing by 74.36%. 
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Table 6 
Dynamics of psychometric indicators (М±m, scores, %) in patients treated with phabomotisol 
and  ionized fluids (n=22) 
 
№ Index  
Terms of observation 
Before reatment After treatment 
1 Anxiety 31.68 ± 1.46 23.55 ± 0.58⃰ (74.32%) 
2 Depression 34.45 ± 1.38 29.23 ± 0.90(⃰84.83%) 
3 Health 29.23 ± 1.32 44.55 ± 1.25⃰ (152.41%) 
4 Activity 30.18 ± 1.05 45.67 ± 0.95⃰ (151.32%) 
5 Mood 28.40 ± 1.16 43.89 ± 1.04* (154.54%) 
Note: * − р<0.05 compared with the indicators before treatment. 
 
In the appointment of IL with negative AFP, 
in conjunction with phabomotisol, the maximum 
increase in the total SAN index was observed by 
52.75% in patients of the fifth group and the 
decrease in anxiety scores by 25.68% (p <0.05), 
which is associated with a positive 
pharmacodynamic interaction of the drugs. In 
addition, the conducted correlation analysis 
demonstrated the dependence of the amount of 
dermatological index of acne and indices of the 
psychological profile, in particular – values of the 
scale of anxiety. Among patients who received 
phabomotisol and ionized fluids, an increase in 
the correlation coefficient was revealed (Table 7), 
which indicates an increase in the relationship 
between DIA indices and anxiety after the 
therapy. 
Table 7 
Spearman correlation coefficients for anxiety and 
DIA 
 
Number 
Before 
treatment 
After 
treatment 
Group 1 0.261 0.001 
Group 2 0.198 0.357 
Group 3 0.303 0.424* 
Group 4 0.332 0.311 
Group 5 0.315 0.398 
Note: * – Correlation is significant at the level of 0.05 
(two-sided).  
 
In the results of the research, the effect on the 
immune processes of a combination of ionized 
liquid with negative AFP and a psychotropic drug 
was demonstrated. The absence of significant 
changes in the immune response, when standard 
drugs and phabomotisol are included in the 
treatment program, allows us to state that IL with 
negative AFP has an immunotropic action. 
One of the important indicators of the 
effectiveness of therapy is the duration of 
remission. The data of the study convincingly 
testify that remission for more than a year 
occurred in 22.7% of patients in the fifth group 
and in no one as a result of the application of a 
standard therapy regimen. As a result of the 
inclusion in the treatment program of acne 
phabomotisol and ionized fluids with different 
AFP on the background of combined topical 
drugs, the incidence of side effects decreased 
from 81.2% to 4.5% of cases. 
Conclusion 
The thesis presents the results of studying the 
effect of preparations of a complex 
pharmacotherapeutic regimen for the correction 
of immunological, psychoemotional changes and 
cutaneous manifestations of acne on the course of 
the examined dermatosis. In the course of the 
study, an effective way of standard topical 
combined agents not including retinoid-like 
substances on the pathological processes in the 
hair follicle and skin manifestations of acne was 
suggested. Given the role of stress in the 
implementation of the cascade of pathogenetic 
mechanisms of acne, including changes in the 
local and systemic immune response, new tools 
have been proposed to correct psychoemotional 
and immunological changes in patients with acne. 
The effectiveness of the assignment of 
ionized liquids, which we use for the first time in 
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complex therapy of moderate acne, has been 
proved in the work. The physicochemical 
properties of the ionized liquid with negative AFP 
made it possible to assume the presence of its 
immunotropic properties, which was confirmed in 
the course of the study. In addition, it was proved 
that the therapeutic effect, expressed in the 
reduction of cutaneous manifestations of acne and 
the onset of a prolonged remission, was achieved 
without the use of systemic antibiotics with the 
minimum frequency of side effects. 
Summing up, we can draw the following 
conclusions: 
1. The use of standard therapy provides a 
reduction in the DIA index by 33.12% and does 
not lead to a stable remission. Side effects of 
therapy are recorded in 81.8% of cases. 
2. When using monotherapy with combined 
topical agents, the DIA index decreases by an 
average of 48.75%, remission for more than a half 
of a year is achieved in 46.4% of cases. 
3. The inclusion in the treatment of 
moderately severe acne of fabomotizol at a dose 
of 5 mg 3 times a day during the month positively 
affects the clinical picture of the disease and the 
psychometric parameters of patients (DIA after 6 
months decreases by 56.41%) and does not affect 
the immune status. Undesirable effects of the 
therapy are recorded in 9.1% of patients. 
4. The use of an ionized liquid with negative 
AFP at a dose of 2 ml / kg of body weight 1 time 
per day for two weeks in patients with acne leads 
to an increase in CD4+ lymphocytes by 14.48%, 
an immunoregulatory index by 40.88% and a 
decrease in the number of CD8+ cytotoxic 
lymphocytes by 17.92%. 
5. The maximum decline in the DIA index 
(by 74.36%) and long-term clinical recovery 
(remission of more than a year in 22.7% of cases) 
with a minimum incidence of side effects (in 4, 
5% of cases) was achieved by including in the 
treatment program phabomotisol and ionized 
liquids with different redox potential. 
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